Mettler-Toledo International (NYSE:MTD) Given New $1,200.00 Price Target at Wells Fargo & Company

Mettler-Toledo International (NYSE:MTD) had its target price raised by Wells Fargo & Company from $1,125.00 to $1,200.00 in a research note released on Monday,Benzinga reports. The brokerage currently has an equal weight rating on the medical instruments supplier’s stock.

Other research analysts have also recently issued research reports about the company. Robert W. Baird dropped their price target on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a “neutral” rating for the company in a research report on Tuesday, April 22nd. Citigroup upgraded shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,400.00 target price for the company in a research report on Monday, April 7th. Jefferies Financial Group upgraded shares of Mettler-Toledo International from an “underperform” rating to a “hold” rating and lowered their price target for the company from $1,200.00 to $1,110.00 in a research report on Monday. Finally, Evercore ISI lifted their price objective on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a research report on Monday, February 10th. Seven research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $1,296.13.

Mettler-Toledo International Stock Down 0.9 %

Shares of NYSE MTD opened at $1,090.24 on Monday. The business has a 50-day moving average price of $1,132.87 and a 200 day moving average price of $1,229.48. The stock has a market cap of $22.72 billion, a PE ratio of 26.90, a price-to-earnings-growth ratio of 3.30 and a beta of 1.40. Mettler-Toledo International has a 52-week low of $946.69 and a 52-week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, beating the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. The firm had revenue of $883.74 million during the quarter, compared to the consensus estimate of $876.61 million. During the same period in the prior year, the business earned $8.89 EPS. The firm’s revenue was down 4.6% compared to the same quarter last year. Sell-side analysts anticipate that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Insider Transactions at Mettler-Toledo International

In other news, insider Christian Magloth sold 790 shares of the business’s stock in a transaction on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the transaction, the insider now owns 734 shares of the company’s stock, valued at approximately $964,248.46. The trade was a 51.84 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Gerry Keller sold 600 shares of the company’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the completion of the transaction, the insider now owns 6 shares of the company’s stock, valued at approximately $8,108.04. This trade represents a 99.01 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company’s stock.

Institutional Trading of Mettler-Toledo International

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. SBI Securities Co. Ltd. bought a new stake in Mettler-Toledo International in the fourth quarter worth about $33,000. Edmond DE Rothschild Holding S.A. bought a new stake in Mettler-Toledo International during the fourth quarter worth approximately $44,000. Golden State Wealth Management LLC grew its position in Mettler-Toledo International by 583.3% in the first quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier’s stock worth $48,000 after buying an additional 35 shares during the last quarter. Blue Trust Inc. increased its holdings in shares of Mettler-Toledo International by 70.8% in the fourth quarter. Blue Trust Inc. now owns 41 shares of the medical instruments supplier’s stock valued at $50,000 after buying an additional 17 shares in the last quarter. Finally, Whipplewood Advisors LLC acquired a new stake in shares of Mettler-Toledo International during the 4th quarter valued at $54,000. 95.07% of the stock is currently owned by institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.